Try our beta test site
3 studies found for:    (lymphoma [CONDITION] OR CLL [CONDITION]) AND Pomalidomide [TREATMENT] | Open Studies
Show Display Options
Rank Status Study
1 Recruiting An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, With or Without Pomalidomide and Dexamethasone, in Patients With Multiple Myeloma
Conditions: Non-Hodgkin's Lymphoma;   Hodgkin Lymphoma;   Multiple Myeloma
Interventions: Biological: Nivolumab;   Biological: Ipilimumab;   Biological: Lirilumab;   Biological: Daratumumab;   Drug: Pomalidomide;   Drug: Dexamethasone
2 Recruiting Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas
Conditions: Chronic Lymphocytic Leukemia;   B-Cell Lymphoma
Interventions: Drug: DTRMWXHS-12;   Drug: DTRM-505;   Drug: DTRM-555
3 Recruiting Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
Conditions: Multiple Myeloma;   Lymphoma, Large B-Cell, Diffuse;   Pleiotropic Pathway Modifier;   Glioblastoma;   Lymphoma;   Primary Central Nervous System Lymphoma (PCNSL)
Intervention: Drug: CC-122

Study has passed its completion date and status has not been verified in more than two years.